Merck & Co. Agrees to Buy Cubist in US$9.5 B Deal to Strengthen its Acute Care Portfolio
By Heather Cartwright
Pharma Deals Review: Vol 2014 Issue 12 (Table of Contents)
Published: 26 Dec-2014
DOI: 10.3833/pdr.v2014.i12.2085 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Continuing its bolt-on acquisition strategy, Merck & Co...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS